- Home
- DTSQ vs HLVX Comparison
DTSQ vs HLVX Comparison
Compare DTSQ & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSQ
- HLVX
- Stock Information
- Founded
- DTSQ 2022
- HLVX 2020
- Country
- DTSQ United States
- HLVX United States
- Employees
- DTSQ N/A
- HLVX N/A
- Industry
- DTSQ
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- DTSQ
- HLVX Health Care
- Exchange
- DTSQ NYSE
- HLVX Nasdaq
- Market Cap
- DTSQ 91.7M
- HLVX 83.7M
- IPO Year
- DTSQ 2024
- HLVX 2022
- Fundamental
- Price
- DTSQ $10.39
- HLVX $2.06
- Analyst Decision
- DTSQ
- HLVX Hold
- Analyst Count
- DTSQ 0
- HLVX 1
- Target Price
- DTSQ N/A
- HLVX $2.00
- AVG Volume (30 Days)
- DTSQ 3.5K
- HLVX 386.3K
- Earning Date
- DTSQ 01-01-0001
- HLVX 08-07-2025
- Dividend Yield
- DTSQ N/A
- HLVX N/A
- EPS Growth
- DTSQ N/A
- HLVX N/A
- EPS
- DTSQ 0.28
- HLVX N/A
- Revenue
- DTSQ N/A
- HLVX N/A
- Revenue This Year
- DTSQ N/A
- HLVX N/A
- Revenue Next Year
- DTSQ N/A
- HLVX N/A
- P/E Ratio
- DTSQ $37.10
- HLVX N/A
- Revenue Growth
- DTSQ N/A
- HLVX N/A
- 52 Week Low
- DTSQ $9.96
- HLVX $1.34
- 52 Week High
- DTSQ $10.53
- HLVX $2.17
- Technical
- Relative Strength Index (RSI)
- DTSQ N/A
- HLVX 53.77
- Support Level
- DTSQ N/A
- HLVX $2.09
- Resistance Level
- DTSQ N/A
- HLVX $2.17
- Average True Range (ATR)
- DTSQ 0.00
- HLVX 0.08
- MACD
- DTSQ 0.00
- HLVX 0.00
- Stochastic Oscillator
- DTSQ 0.00
- HLVX 52.17
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.